The Scan | GenomeWeb

The Scan

From the Overhead

ScienceInsider reports that the Trump Administration budget blueprint may also include cuts to indirect costs.

Call for Guidance

Harvard researchers call for a discussion and development of guidelines for 'embryoid' research, NPR reports.

This Week in PNAS

In PNAS this week: transcriptional patterns in breast cancer cell lines, study of non-CG methylation, and more.

Lower, But…

A trial of a drug that mimics a PCSK9 gene mutation doesn't quite meet expectations, both Nature News and Forbes say.

Excitement and Risk

CRISPR may make gene-editing easier, but it may also make regulation harder, according to New Scientist.

About a Degree

Buzzfeed News reports that Freenome CEO Gabriel Otte, despite some descriptions stating otherwise, did not receive a PhD.

This Week in PLOS

In PLOS this week: COLEC10 linked to craniofacial development, transcripts and peptides of spider venom, and more.

UK regulators have given the clinic the green light to offer the service, the Guardian reports.

Placental examination, fetal autopsy, and genetic testing are among the most useful tests when searching for stillbirth cause, the New York Times reports.

Follow the DNA

The Economist reports that companies are testing out using DNA as a tracer molecule to map underground resources.

This Week in Science

In Science this week: applying genome-editing technologies to crops, and more.

President Donald Trump's budget blueprint includes a nearly 20 percent cut for the National Institutes of Health.

Columbia University researchers uncover a gene variant associated with differential aging in the brain after the age of 65.

From Pigs to People

A startup company is betting that CRISPR could be used to enable xenotransplantation from pigs to humans, Technology Review reports.

This Week in Nature

In Nature this week: 3D genome structures, CRISPR approach prevents retinitis pigmentosa in mice, and more.

Which'll Be First?

Researchers are focusing on diseases caused by single, rare mutations as initial CRISPR therapy targets, CNBC reports.

In at PLOS One

Retraction Watch speaks with PLOS One's new editor about the journal's decline in the number of papers published and his plans for the journal.

Researchers link a serotonin transporter gene variant to social anxiety disorder risk, Psychology Today reports.

In Nucleic Acids Research this week: isomiR-based cancer classifier, map of VjbR binding in Brucella, and more.

Centers for Medicare & Medicaid Services pick Seema Verma has been confirmed, the Wall Street Journal reports.

Here it Comes

ScienceInsider reports that UK researchers are bracing themselves for the coming Brexit.

NPR reports that even with the advent of targeted cancer treatments, there's still a place for chemotherapy.

This Week in PNAS

In PNAS this week: antibiotic component may suppress nonsense mutations, long-fingered bat genome includes endogenous retrovirus not found in other bats, and more.

President Donald Trump taps Scott Gottlieb, an American Enterprise Institute fellow, to run the Food and Drug Administration.

The Family Variant

The Columbus Dispatch tells the story of two sisters who've inherited a rare genetic illness.


At Science Careers, Princeton University's Julian West advises new researchers to read widely.

At Science Careers, a researcher describes how her rejuvenated postdoc science policy committee is promoting science.

Bitesize Bio's Gail Seigel offers some tips on running a low-budget lab.

The GRE isn't a good predictor of graduate school performance or productivity, according to two PLOS One studies.